Discovery & Validation

The M2Gen® mission is to continue to grow as the preferred and most trusted service provider in the personalized medicine industry and the premier choice for tissue and clinical data solutions for biopharmaceutical companies. As a global leader in tissue and data resources, M2Gen brings together targeted discovery solutions and bioinformatics to a vastly growing international biopharmaceutical client and hospital consortium base.

M2Gen is home to the world’s largest cancer-focused biorepository linked to longitudinal clinical and molecular data. Our collaborative work on 45+ studies with our biopharmaceutical client has resulted in providing assay development, biomarker validation, pathway activation assessments, and signature correlations. We are in a unique position to facilitate biomarker discovery, validation, and commercialization in the diagnostic marketplace.